Please login to the form below

Not currently logged in
Email:
Password:

Amgen promotes Esteban Santos

He succeeds Madhavan Balachandran as executive vice president of operations

Amgen Esteban SantosAmgen has appointed Esteban Santos as executive vice president of operations, with effect from 25 July.

In his new role Santos will take on responsibility for Amgen's operations, which encompasses manufacturing, process development, quality, engineering and its global supply chain, from Madhavan Balachandran who retires at the end of the year.

Santos joined the California-based biotech in 2007 as vice president of global engineering, and subsequently held a number of roles with increasing responsibility at the firm.

He currently serves as senior vice president of manufacturing with responsibility for worldwide product supply - a position he has held since 2013.

Prior to joining Amgen, Santos worked at Cordis, a Johnson & Johnson company, as site general manager for its Puerto Rico operations.

He has also held several management positions at General Electric, including its industrial and transportation businesses in Connecticut, Puerto Rico and Pennsylvania.

Robert Bradway, chairman and chief executive officer at Amgen, said: “Esteban is a talented leader with a proven track record.

“I'm confident that Esteban and our operations team will maintain our track record of industry-leading performance in serving 'every patient, every time' as we expand globally, launch new products and introduce our next-generation of biomanufacturing technologies.”

21st June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics